Daily Anesthesiology Research Analysis
Analyzed 95 papers and selected 3 impactful papers.
Summary
Three impactful perioperative anesthesia papers stood out: a meta-analysis suggests dural puncture epidural or combined spinal-epidural with 24–25G spinal needles does not meaningfully raise post–dural puncture headache risk; a systematic review of RCTs shows dexmedetomidine halves postoperative delirium after brain surgery; and a 96,103-case study quantifies the extremely low incidence of neuraxial epidural hematoma in arthroplasty, informing risk counseling and management.
Research Themes
- Perioperative neuraxial anesthesia safety
- Evidence synthesis guiding practice (meta-analyses in anesthesia)
- Delirium prevention strategies in neurosurgical anesthesia
Selected Articles
1. Post-dural Puncture Headache in Dural Puncture Epidural and Combined Spinal-Epidural Using 24- and 25-Gauge Needles Versus Conventional Epidural Labor Analgesia: A Systematic Review and Meta-analysis.
Across 16 RCTs (n=3,278) using 24–25G spinal needles, headache rates after DPE/CSE versus conventional epidural were very low and not statistically different with wide credible intervals due to rarity of events. Findings suggest DPE/CSE with larger spinal needles does not meaningfully increase PDPH compared with epidural, though precision is limited.
Impact: Addresses a central safety concern limiting adoption of DPE/CSE by quantifying PDPH risk specifically with clinically effective (24–25G) spinal needles.
Clinical Implications: Supports the safety of DPE/CSE with 24–25G needles regarding PDPH risk, allowing clinicians to prioritize analgesic benefits without substantial added headache risk; however, definitive guidance awaits large RCTs with PDPH as the primary outcome.
Key Findings
- Total N=3,278 across 16 RCTs: 1,765 epidural, 971 DPE, 542 CSE.
- Headache rates were low: 0.59% (CSE/DPE) vs 0.34% (epidural).
- Bayesian log OR ~0.35 favored epidural but with wide 95% CI (−0.49 to 1.22) due to rare events; in 10/16 RCTs, zero headaches occurred.
Methodological Strengths
- Focused exclusively on 24–25G spinal needles relevant to DPE/CSE efficacy.
- Comprehensive database search with RoB 2 assessment and Bayesian estimation.
Limitations
- PDPH was a secondary endpoint in all included RCTs with very low event rates, limiting precision.
- Heterogeneity in labor analgesia protocols and follow-up timing across trials.
Future Directions: A large, adequately powered, CONSORT-compliant RCT with PDPH as the primary endpoint and standardized follow-up to precisely estimate PDPH risk with DPE/CSE using 24–25G needles.
BACKGROUND: Compared to standard labor epidurals, placement of a dural puncture epidural (DPE) has been shown to improve labor analgesia efficacy, speed onset of analgesia, and decrease failure rates. However, there is a concern of increased post-dural puncture headache (PDPH) risk. A 25-gauge or larger spinal needle is typically needed for a DPE to have improved efficacy over a standard epidural. A prior meta-analysis comparing combined spinal-epidurals (CSEs) with epidurals did not identify a difference in PDPH rates, but many of the included randomized contro
2. Efficacy of Dexmedetomidine in Preventing Postoperative Delirium in Patients Undergoing Brain Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
In five RCTs totaling 646 adults undergoing brain surgery, perioperative dexmedetomidine reduced postoperative delirium by 53% (RR 0.47; 95% CI 0.35–0.63) without detectable heterogeneity. These findings support dexmedetomidine as an effective adjunct for delirium prevention in neurosurgical anesthesia.
Impact: Delirium prevention is a major unmet need after brain surgery; a robust pooled effect suggests a clinically meaningful, scalable strategy with an established drug.
Clinical Implications: Supports incorporating dexmedetomidine into neurosurgical perioperative pathways to lower delirium risk, with attention to dosing and monitoring; local protocols should align with unit resources and patient factors.
Key Findings
- Five RCTs (n=646) showed dexmedetomidine reduced postoperative delirium (RR 0.47; 95% CI 0.35–0.63; p<0.00001).
- Dosing regimens ranged from 0.5–1 μg/kg loading over 10 min with 0.1–0.5 μg/kg/h maintenance.
- No statistical heterogeneity was detected, supporting consistency across trials.
Methodological Strengths
- PRISMA-guided systematic review and meta-analysis restricted to RCTs.
- Consistent direction of effect with no detected heterogeneity.
Limitations
- Limited number of trials and variations in dosing strategies and perioperative contexts.
- Potential publication bias cannot be fully excluded.
Future Directions: Multicenter, adequately powered RCTs to define optimal dosing, timing, safety monitoring, and cost-effectiveness of dexmedetomidine for delirium prevention in neurosurgical pathways.
BACKGROUND: Dexmedetomidine (DEX), a selective alpha-2 adrenergic receptor agonist, is widely used in various surgical settings, including cardiac and general surgeries, for its sedative, analgesic, and neuroprotective properties. Patients undergoing brain surgery are particularly susceptible to postoperative delirium (POD). Given the established benefits of dexmedetomidine in other surgical fields, its potential to mitigate delirium in neurosurgery warrants investigation. METHODS: A systematic search of PubMed, Embase, Scopus, and Cochrane databases was conduct
3. Incidence of spinal-epidural haematoma after neuraxial anaesthesia for total hip and knee arthroplasty: a single-centre analysis of 96 103 consecutive cases from 2013 to 2023.
In 96,103 consecutive arthroplasty neuraxial anesthetics, symptomatic or radiographic epidural hematoma occurred only with epidural-based techniques (epidural or combined spinal–epidural), at an estimated frequency of ~1:10,000; none occurred after spinal anesthesia among 75,205 cases. The authors provide an interdisciplinary management algorithm.
Impact: Provides a precise, contemporary risk estimate for a rare but catastrophic neuraxial complication in a common surgical population, informing consent and technique selection.
Clinical Implications: Supports spinal anesthesia as having extremely low risk of epidural hematoma in arthroplasty and quantifies risk with epidural-based techniques; facilitates informed consent, anticoagulation timing decisions, and rapid response pathways.
Key Findings
- Total 96,103 neuraxial anesthetics: 75,205 spinal; 1,588 epidural; 19,310 combined spinal–epidural.
- Two EH cases identified: one symptomatic requiring decompression after CSE; one asymptomatic after epidural managed conservatively.
- Estimated frequencies: ~1:10,000 for epidural/CSE (95% CI 0.1–3.5:10,000); 0:75,000 for spinal (95% CI 0–0.05:10,000).
Methodological Strengths
- Very large consecutive cohort with dual-database case ascertainment (radiology and QA).
- Clear denominator stratified by neuraxial technique enabling procedure-specific incidence estimates.
Limitations
- Retrospective single-center design with potential under-ascertainment of clinically silent cases not imaged.
- Findings may not generalize to non-arthroplasty populations or centers with different practices.
Future Directions: Multicenter registry studies to refine incidence by anticoagulation status, timing, and catheter management, and to validate management algorithms.
BACKGROUND: Epidural haematoma (EH) is a rare but serious complication of neuraxial anaesthesia. The incidence varies in the published literature, and contemporary procedure- and population-specific estimates are lacking. We estimated the incidence of EH after neuraxial anaesthesia for total joint arthroplasty. We further present an evidence-based algorithm for interdisciplinary management. METHODS: This is a single-centre, retrospective analysis of consecutive patients who underwent primary unilateral or bilateral total hip or knee arthroplasty under spinal, epidural, or